Wyeth Sues To Protect Its Best-Selling Drug
Wyeth has filed a patent infringement suit against Osmotica Pharmaceutical Corp., accusing Osmotica of seeking regulatory approval to market a knockoff of the extended-release form of Wyeth's blockbuster depression and anxiety...To view the full article, register now.
Already a subscriber? Click here to view full article